405 related articles for article (PubMed ID: 28698504)
1. Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer.
Tazawa H; Kuroda S; Hasei J; Kagawa S; Fujiwara T
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698504
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic adenovirus-induced autophagy: tumor-suppressive effect and molecular basis.
Tazawa H; Kagawa S; Fujiwara T
Acta Med Okayama; 2013; 67(6):333-42. PubMed ID: 24356717
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between oncolytic viruses and autophagy in cancer therapy.
Jin KT; Tao XH; Fan YB; Wang SB
Biomed Pharmacother; 2021 Feb; 134():110932. PubMed ID: 33370632
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic adenoviruses for the treatment of brain tumors.
Gomez-Manzano C; Fueyo J
Curr Opin Mol Ther; 2010 Oct; 12(5):530-7. PubMed ID: 20886384
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients.
Liikanen I; Ahtiainen L; Hirvinen ML; Bramante S; Cerullo V; Nokisalmi P; Hemminki O; Diaconu I; Pesonen S; Koski A; Kangasniemi L; Pesonen SK; Oksanen M; Laasonen L; Partanen K; Joensuu T; Zhao F; Kanerva A; Hemminki A
Mol Ther; 2013 Jun; 21(6):1212-23. PubMed ID: 23546299
[TBL] [Abstract][Full Text] [Related]
6. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
[TBL] [Abstract][Full Text] [Related]
7. Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia.
Tong Y; You L; Liu H; Li L; Meng H; Qian Q; Qian W
Oncotarget; 2013 Jun; 4(6):860-74. PubMed ID: 23765161
[TBL] [Abstract][Full Text] [Related]
8. Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation.
Rajecki M; af Hällström T; Hakkarainen T; Nokisalmi P; Hautaniemi S; Nieminen AI; Tenhunen M; Rantanen V; Desmond RA; Chen DT; Guse K; Stenman UH; Gargini R; Kapanen M; Klefström J; Kanerva A; Pesonen S; Ahtiainen L; Hemminki A
Int J Cancer; 2009 Nov; 125(10):2441-9. PubMed ID: 19672857
[TBL] [Abstract][Full Text] [Related]
9. Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer.
Ma J; Ramachandran M; Jin C; Quijano-Rubio C; Martikainen M; Yu D; Essand M
Cell Death Dis; 2020 Jan; 11(1):48. PubMed ID: 31969562
[TBL] [Abstract][Full Text] [Related]
10. Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo.
Gomez-Gutierrez JG; Nitz J; Sharma R; Wechman SL; Riedinger E; Martinez-Jaramillo E; Sam Zhou H; McMasters KM
Virology; 2016 Jan; 487():249-59. PubMed ID: 26561948
[TBL] [Abstract][Full Text] [Related]
11. Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells.
Hasei J; Sasaki T; Tazawa H; Osaki S; Yamakawa Y; Kunisada T; Yoshida A; Hashimoto Y; Onishi T; Uno F; Kagawa S; Urata Y; Ozaki T; Fujiwara T
Mol Cancer Ther; 2013 Mar; 12(3):314-25. PubMed ID: 23315976
[TBL] [Abstract][Full Text] [Related]
12. Cancer cell death by design: apoptosis, autophagy and glioma virotherapy.
Tyler MA; Ulasov IV; Lesniak MS
Autophagy; 2009 Aug; 5(6):856-7. PubMed ID: 19430207
[TBL] [Abstract][Full Text] [Related]
13. C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy.
Klein SR; Piya S; Lu Z; Xia Y; Alonso MM; White EJ; Wei J; Gomez-Manzano C; Jiang H; Fueyo J
Oncogene; 2015 Oct; 34(41):5295-301. PubMed ID: 25619840
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX.
Kaverina NV; Kadagidze ZG; Borovjagin AV; Karseladze AI; Kim CK; Lesniak MS; Miska J; Zhang P; Baryshnikova MA; Xiao T; Ornelles D; Cobbs C; Khramtsov A; Ulasov IV
Oncogene; 2018 Nov; 37(46):6069-6082. PubMed ID: 29991800
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy.
Keshavarz M; Solaymani-Mohammadi F; Miri SM; Ghaemi A
J Biomed Sci; 2019 Jun; 26(1):48. PubMed ID: 31217023
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in oncolytic adenovirus therapies for cancer.
Rosewell Shaw A; Suzuki M
Curr Opin Virol; 2016 Dec; 21():9-15. PubMed ID: 27379906
[TBL] [Abstract][Full Text] [Related]
17. Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells.
Yokoyama T; Iwado E; Kondo Y; Aoki H; Hayashi Y; Georgescu MM; Sawaya R; Hess KR; Mills GB; Kawamura H; Hashimoto Y; Urata Y; Fujiwara T; Kondo S
Gene Ther; 2008 Sep; 15(17):1233-9. PubMed ID: 18580968
[TBL] [Abstract][Full Text] [Related]
18. Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens.
Klein SR; Jiang H; Hossain MB; Fan X; Gumin J; Dong A; Alonso MM; Gomez-Manzano C; Fueyo J
PLoS One; 2016; 11(4):e0153814. PubMed ID: 27093696
[TBL] [Abstract][Full Text] [Related]
19. Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis.
Tazawa H; Yano S; Yoshida R; Yamasaki Y; Sasaki T; Hashimoto Y; Kuroda S; Ouchi M; Onishi T; Uno F; Kagawa S; Urata Y; Fujiwara T
Int J Cancer; 2012 Dec; 131(12):2939-50. PubMed ID: 22492316
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy.
Ulasov IV; Shah N; Kaverina NV; Lee H; Lin B; Lieber A; Kadagidze ZG; Yoon JG; Schroeder B; Hothi P; Ghosh D; Baryshnikov AY; Cobbs CS
Oncotarget; 2015 Feb; 6(6):3977-87. PubMed ID: 25738357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
